PillRx only · Capsule · Oral
Aprepitant
Brands: Emend · Aprepitant
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages28
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$73.365
Latest avg · Jun 17, 2026
-65%
Since Jan 22, 2025
6
Active US suppliers
39%
Top-2 supplier share*
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc., USA | unknown | 6 | SUPPLYING |
| Sandoz Inc | unknown | 5 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 5 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 5 | SUPPLYING |
| BluePoint Laboratories | unknown | 5 | SUPPLYING |
| Merck Sharp & Dohme LLC. | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.